1.7499
                                            Prelude Therapeutics Inc 주식(PRLD)의 최신 뉴스
PRLD's Financial Outlook: Cash Runway Extended to 2027 - GuruFocus
Incyte (INCY) Secures Option for JAK2V617F Program in $910M Deal - GuruFocus
Incyte (INCY) Secures Exclusive Option on JAK2V617F Program - GuruFocus
Prelude Therapeutics stock climbs after exclusive JAK2 option deal with Incyte - Investing.com India
A Look at Prelude Therapeutics Inc (PRLD) Shares in the Recent Past Indicates Growth - setenews.com
Prelude Therapeutics Announces Strategic Updates: Prioritizes JAK2V617F and KAT6A Programs, Pauses SMARCA2 Development and Secures $60 Million from Incyte Option Agreement - Quiver Quantitative
Prelude Therapeutics Announces Strategic Business Update - Yahoo Finance
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors - Yahoo Finance
Is Prelude Therapeutics Incorporated stock supported by innovation pipelineJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Can Prelude Therapeutics Incorporated stock sustain free cash flow growth2025 Price Targets & AI Enhanced Trading Signals - newser.com
Can Prelude Therapeutics Incorporated stock hit analyst price targetsMarket Weekly Review & Safe Capital Growth Tips - newser.com
Will Prelude Therapeutics Incorporated stock deliver shareholder valueSwing Trade & Safe Investment Capital Preservation Plans - newser.com
What institutional flow reveals about Prelude Therapeutics IncorporatedMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Prelude Therapeutics (PRLD) Projected to Post Earnings on Wednesday - Defense World
Prelude Therapeutics Spikes: Can The Pipeline Keep Up? - RTTNews
Prelude Therapeutics (NASDAQ:PRLD) and CytoDyn (OTCMKTS:CYDY) Financial Analysis - Defense World
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.51% - Investing.com
Prelude Therapeutics (PRLD) to Present Preclinical Findings at A - GuruFocus
Is Prelude Therapeutics Incorporated stock ready for a breakoutQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting - Yahoo Finance
Pattern recognition hints at Prelude Therapeutics Incorporated upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
What to do if you’re stuck in Prelude Therapeutics IncorporatedJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
How Prelude Therapeutics Incorporated stock reacts to oil pricesJuly 2025 Movers & High Accuracy Swing Entry Alerts - newser.com
Is Prelude Therapeutics Incorporated stock a defensive play in 2025Quarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com
Volume spikes in Prelude Therapeutics Incorporated stock – what they meanJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com
Can Prelude Therapeutics Incorporated stock maintain operating marginsJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsPortfolio Performance Report & High Return Trade Guides - newser.com
Prelude Therapeutics Shares Surge on Analyst Optimism and Upcoming Earnings - AD HOC NEWS
Prelude Therapeutics Incorporat (PRLD) stock forecast and price target - Yahoo! Finance UK
What sentiment indicators say about Prelude Therapeutics Incorporated stockWatch List & Verified Technical Trade Signals - newser.com
Using flow based indicators on Prelude Therapeutics IncorporatedDip Buying & Safe Entry Zone Tips - newser.com
How to build a custom watchlist for Prelude Therapeutics Incorporated2025 Investor Takeaways & Weekly Momentum Picks - newser.com
Prelude Therapeutics Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView
What machine learning models say about Prelude Therapeutics IncorporatedTrend Reversal & Reliable Trade Execution Plans - newser.com
Exit strategy if you’re trapped in Prelude Therapeutics IncorporatedJuly 2025 Action & Risk Controlled Swing Trade Alerts - newser.com
How Prelude Therapeutics Incorporated stock performs in interest rate cyclesInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
                자본화:
                 
                  | 
                볼륨(24시간):